Altimmune (ALT) Capital Expenditures (2010 - 2026)
Altimmune's Capital Expenditures was $32,000 in Q2 2026, up 52.4% from the prior quarter.
Powered by 
Analysis
Altimmune (ALT) Capital Expenditures (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Altimmune's Capital Expenditures was $54,000 through Jun 30, 2026; for FY2025, it came in at $11,000.
- Capital Expenditures shows a five-year compound annual growth rate of -44.2% (FY2020 to FY2025).
- In earlier years, Capital Expenditures was $47,000 in FY2023 (-62.7%), $126,000 in FY2022 (-99.0%) and $12.12 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Capital Expenditures since Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Altimmune | 411.69 Mn | -730.54 Mn | - | 32,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32,000.00 |
| Mar 31, 2026 | 21,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Jun 30, 2023 | -4,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | 38,000.00 |
| Sep 30, 2022 | 60,000.00 |
| Jun 30, 2022 | 19,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | 147,000.00 |
| Sep 30, 2021 | 70,000.00 |
| Jun 30, 2021 | 7.69 Mn |
| Mar 31, 2021 | 4.21 Mn |
| Dec 31, 2020 | 103,628.00 |
| Sep 30, 2020 | 59,728.00 |
| Jun 30, 2020 | 22,470.00 |
| Mar 31, 2020 | 18,131.00 |
| Sep 30, 2019 | 1.00 |
| Mar 31, 2019 | 1,226.00 |
| Dec 31, 2018 | 7,053.00 |
API Access
Altimmune Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();